Cipla (CIPLA) Share Price
CIPLA · M.Cap ₹1,13,924 CrCipla trades at 33.95x TTM P/E (vs Pharma & Health sector median of 31.4x) with a 18.7% operating margin and ₹3,356 Cr annual net profit.
₹1,411.00+6.90 (+0.49%)
1M +7.97%·1Y -6.14%·Vol 15,67,019·VWAP ₹1,403.33
CIPLA Share Price Chart & Multi-Horizon Returns
CIPLA · 3M Price Action & VolumeRSI (14)79.7 · Overbought
SMA 20₹1,355.98
SMA 50₹1,367.29
SMA 200₹1,363.43
ATR (14) Volatility1.97%
1M / 3M Return+7.97% / -3.61%
Session Reference & Price Bands
NSE / BSE CashOpen (₹)₹1,387.00
High (₹)₹1,411.00
Low (₹)₹1,382.00
Prev. Close₹1,404.10
Combined Vol16,05,020
VWAP / ATP₹1,403.33
Upper Band₹1,544.51
Lower Band₹1,263.69
52W High (₹)₹1,539.70
52W Low (₹)₹1,165.70
Range Positioning
Spot ₹1,411.00Market Depth & Order Flow (CIPLA)
Combined NSE + BSE Order Book · 5-Level Bid/Ask Microstructure
| Bid Price | Exch | Orders | Qty |
|---|---|---|---|
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| Ask Price | Exch | Orders | Qty |
|---|---|---|---|
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
| 0.00 | NSE | 0 | 0 |
Order Flow Microstructure (XTS 1502): Post-close / Closing Auction snapshot active. Live 10s/30s delta order-flow resumes during continuous trading (09:15–15:30 IST).
Cipla (CIPLA) Consolidated Profit & Loss Statement
Annual Financial Performance (Figures in ₹ Crore)
| Line Item (₹ Cr) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue / Sales | 21,763 | 22,753 | 25,774 | 27,548 | 28,163 | 28,324 |
| Operating Expenses | 17,211 | 17,726 | 19,483 | 20,420 | 22,280 | 23,027 |
| Operating Profit (EBIT/EBITDA) | 4,553 | 5,027 | 6,291 | 7,128 | 5,883 | 5,297 |
| Other Income | 99 | 293 | 552 | 862 | 606 | 558 |
| Interest & Depreciation | 1,158 | 1,282 | 1,141 | 1,169 | 1,265 | 1,319 |
| Profit Before Tax (PBT) | 3,493 |
Multi-Factor Quant Scores & Investment Thesis (CIPLA)
Grounded Factor Decomposition & Institutional Bull vs. Bear Debate
Technicals & Momentum87 / 100
RSI 79.7 · SMA20 ₹1,355.98
Fundamental Quality74 / 100
PAT ₹3,356 Cr · OPM 18.7%
F&O Options Positioning68 / 100
Support ₹1,300.00 · Max Pain ₹1,360.00
Institutional Backing84 / 100
Promoter 29.2% · FII+DII 54.5%
Bull Case & Catalysts
- Strong Put OI Floor at ₹1,300.00: Put writers have accumulated 7,85,400 OI at the ₹1,300.00 strike, acting as an institutional demand zone.
- Resilient Operating Cash & TTM PAT of ₹3,356 Cr: Cipla generated ₹5,297 Cr operating profit on ₹28,324 Cr revenue (18.7% operating margin).
- High Institutional & Promoter Skin-in-the-Game (83.8%): Promoters hold 29.22%, complemented by 20.20% FII and 34.35% DII holdings as of Jun 2026.
Pharma & Health Peer Comparison
Benchmarked by Market Cap, P/E, P/B, Dividend Yield & 1M Returns
| Company | Price (₹) | M.Cap (Cr) | P/E (x) | P/B (x) | Div Yld % | 1M Return |
|---|---|---|---|---|---|---|
| Cipla Ltd. | 1,411.00 | 1,13,924 | 33.95 | 3.31 | 0.83% | +7.97% |
| Sun Pharmaceutical Industries Ltd | 1,864.30 | 4,47,310 | 42.60 | 6.95 | 0.72% | +5.10% |
| Dr. Reddy's Laboratories Ltd | 1,278.50 | 1,06,680 | 19.20 | 3.74 | 0.62% | +2.10% |
CIPLA Options Chain & OI Analytics
Active Expiry: 2026-11-23 · Spot ₹1,411.00 · Max Pain ₹1,360.00
| Call OI | Call LTP | Strike (₹) | Put LTP | Put OI |
|---|---|---|---|---|
| 1.74L | ₹43.00 | 1380.00 | ₹11.25 | 1.02L |
| 0.93L | ₹36.00 | 1390.00 | ₹14.25 | 0.83L |
| 7.25L | ₹29.50 | 1400.00 | ₹18.35 | 2.08L |
| 1.53L | ₹23.95 | 1410.00 (ATM) | ₹21.40 | 0.51L |
| 1.66L | ₹18.95 | 1420.00 | ₹27.10 | 0.18L |
| 1.13L | ₹15.00 | 1430.00 | ₹33.10 | 0.19L |
Grounded Options Insights (2026-11-23):
- Support wall is stronger: Put OI support is more concentrated than call OI resistance.
- Balanced options positioning: Current PCR and OI wall evidence is balanced, so options positioning is not strongly directional.
- Neutral PCR: Put-call OI ratio is near neutral.
CIPLA Latest News & Exchange Filings
Curated Market Updates, Announcements & Sentiment
Cipla Share Price Live Updates: Cipla's Recent Trading Activity
Aarey Drugs & Pharmaceuticals Limited
Board Meeting Intimation |Meeting Date: 14-Nov-2026
Supriya Lifescience Ltd (543434)
Newspaper Advertisement enclosed herewith.
Windlas Biotech Ltd (543329)
Recording of Conference Call